keyword
MENU ▼
Read by QxMD icon Read
search

Australian immunisation

keyword
https://www.readbyqxmd.com/read/29139107/antenatal-influenza-and-pertussis-vaccine-uptake-among-aboriginal-mothers-in-western-australia
#1
Kennia Lotter, Annette K Regan, Tyra Thomas, Paul V Effler, Donna B Mak
BACKGROUND: Antenatal influenza and pertussis vaccination prevent serious disease in mothers and infants. Aboriginal individuals are at increased risk of infection yet little is known about vaccine coverage among Aboriginal mothers. AIMS: To estimate the uptake of influenza and pertussis vaccination among pregnant Aboriginal women in Western Australia and identify barriers and enablers to vaccination. MATERIALS AND METHODS: Four hundred Aboriginal women, aged ≥18 years, who gave birth to a live infant between April and October 2015, were randomly selected and invited to participate in telephone interviews...
November 14, 2017: Australian & New Zealand Journal of Obstetrics & Gynaecology
https://www.readbyqxmd.com/read/29128379/active-sms-based-influenza-vaccine-safety-surveillance-in-australian-children
#2
Alexis Pillsbury, Helen Quinn, Patrick Cashman, Alan Leeb, Kristine Macartney
INTRODUCTION: Australia's novel, active surveillance system, AusVaxSafety, monitors the post-market safety of vaccines in near real time. We analysed cumulative surveillance data for children aged 6 months to 4 years who received seasonal influenza vaccine in 2015 and/or 2016 to determine: adverse event following immunisation (AEFI) rates by vaccine brand, age and concomitant vaccine administration. METHODS: Parent/carer reports of AEFI occurring within 3 days of their child receiving an influenza vaccine in sentinel immunisation clinics were solicited by Short Message Service (SMS) and/or email-based survey...
November 8, 2017: Vaccine
https://www.readbyqxmd.com/read/29127227/protocol-for-hospital-based-surveillance-of-cerebral-palsy-cp-in-hanoi-using-the-paediatric-active-enhanced-disease-surveillance-mechanism-paeds-vietnam-a-study-towards-developing-hospital-based-disease-surveillance-in-vietnam
#3
Gulam Khandaker, Nguyen Van Bang, Trịnh Quang Dũng, Nguyen Thi Huong Giang, Cao Minh Chau, Nguyen Thi Van Anh, Nguyen Van Thuong, Nadia Badawi, Elizabeth J Elliott
INTRODUCTION: The epidemiology, pathogenesis, management and outcomes of cerebral palsy (CP) in low-income and middle-income countries including Vietnam are unknown because of the lack of mechanisms for standardised collection of data. In this paper, we outline the protocol for developing a hospital-based surveillance system modelled on the Paediatric Active Enhanced Disease Surveillance (PAEDS) system in Australia. Using PAEDS-Vietnam we will define the aetiology, motor function and its severity, associated impairments, and nutritional and rehabilitation status of children with CP in Hanoi, Vietnam...
November 9, 2017: BMJ Open
https://www.readbyqxmd.com/read/29092707/determining-the-contribution-of-em-streptococcus-pneumoniae-em-to-community-acquired-pneumonia-in-australia
#4
REVIEW
J Kevin Yin, Sanjay H Jayasinghe, Patrick G Charles, Catherine King, Clayton K Chiu, Robert I Menzies, Peter B McIntyre
OBJECTIVE: To evaluate trends in the proportion and severity of community-acquired pneumonia (CAP) attributable to Streptococcus pneumoniae (pneumococcus) in Australians aged 18 years and over. STUDY DESIGN: Systematic review with unpublished data from the largest study. DATA SOURCES: Multiple key bibliographic databases to June 2016. STUDY SELECTION: Australian studies on the aetiology of CAP in adults. DATA SYNTHESIS: In the 12 studies identified, pneumococcus was the most common cause of CAP...
November 6, 2017: Medical Journal of Australia
https://www.readbyqxmd.com/read/29092704/epidemiology-of-invasive-meningococcal-b-disease-in-australia-1999-2015-priority-populations-for-vaccination
#5
Brett N Archer, Clayton K Chiu, Sanjay H Jayasinghe, Peter C Richmond, Jodie McVernon, Monica M Lahra, Ross M Andrews, Peter B McIntyre
OBJECTIVES: To describe trends in the age-specific incidence of serogroup B invasive meningococcal disease (IMD) in Australia, 1999-2015. DESIGN, SETTING, PARTICIPANTS: Analysis in February 2017 of de-identified notification data from the Australian National Notifiable Diseases Surveillance System of all notifications of IMD in Australia with a recorded diagnosis date during 1999-2015.Major outcomes: IMD notification rates in Australia, 1999-2015, by age, serogroup, Indigenous status, and region...
November 6, 2017: Medical Journal of Australia
https://www.readbyqxmd.com/read/29069315/the-impact-of-pneumococcal-vaccination-on-bacterial-and-viral-pneumonia-in-western-australian-children-record-linkage-cohort-study-of-469-589-births-1996-2012
#6
Parveen Fathima, Christopher C Blyth, Deborah Lehmann, Faye J Lim, Tasnim Abdalla, Nicholas de Klerk, Hannah C Moore
Background: Pneumococcal conjugate vaccine (PCV) was included in Australia's National Immunisation Program for all children from 2005. We assessed the impact of PCV on all-cause and pathogen-specific pneumonia hospitalisations in Western Australian (WA) children aged ≤16 years. Methods: All hospitalisations with pneumonia-related ICD-10AM diagnosis codes occurring in WA-born children (1996-2012) were linked to pathology records. Age-specific incidence rate ratios and temporal trends for all-cause and pathogen-specific pneumonia hospitalisations were calculated pre- and post-PCV introduction...
October 23, 2017: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/29029940/antibody-dependent-phagocytosis-adp-responses-following-trivalent-inactivated-influenza-vaccination-of-younger-and-older-adults
#7
Fernanda Ana-Sosa-Batiz, Angus P R Johnston, P Mark Hogarth, Bruce D Wines, Ian Barr, Adam K Wheatley, Stephen J Kent
Globally the most commonly utilised immunisation against influenza is the trivalent inactivated influenza vaccine (TIV) derived from an A/H1N1, an A/H3N2 and aB type influenza virus. Vaccine effectiveness of TIV varies year to year, depending on how well antigenically matched the strains in the vaccine are compared to circulating strains [1,2]. Moreover, vaccine effectiveness can vary within certain subpopulations such as HIV-positive, young children and the elderly. Decreased vaccine effectiveness in the elderly is associated with impaired Ab production, as measured by standard hemagglutination inhibition (HAI) assays...
November 7, 2017: Vaccine
https://www.readbyqxmd.com/read/28894312/-there-s-no-touching-in-pharmacy-training-pharmacists-for-australia-s-first-pharmacist-immunization-pilot
#8
Esther T L Lau, Michelle E Rochin, Megan DelDot, Beverley D Glass, Lisa M Nissen
BACKGROUND: Vaccination is a safe, efficient, and cost-effective means of preventing, controlling, and eradicating many life-threatening infections and diseases. Globally, the World Health Organization estimates that vaccination saves between 2 million and 3 million lives annually. However, low immunization rates are a significant public health concern. Individual factors, along with the vaccination process and system, have been reported as perceived barriers and challenges to immunization...
July 2017: Canadian Journal of Hospital Pharmacy
https://www.readbyqxmd.com/read/28811050/vaccine-decision-making-begins-in-pregnancy-correlation-between-vaccine-concerns-intentions-and-maternal-vaccination-with-subsequent-childhood-vaccine-uptake
#9
M H Danchin, J Costa-Pinto, K Atwell, H Willaby, K Wiley, M Hoq, J Leask, K P Perrett, Jacinta O'Keefe, M L Giles, H Marshall
INTRODUCTION: Maternal and childhood vaccine decision-making begins prenatally. Amongst pregnant Australian women we aimed to ascertain vaccine information received, maternal immunisation uptake and attitudes and concerns regarding childhood vaccination. We also aimed to determine any correlation between a) intentions and concerns regarding childhood vaccination, (b) concerns about pregnancy vaccination, (c) socioeconomic status (SES) and (d) uptake of influenza and pertussis vaccines during pregnancy and routine vaccines during childhood...
August 12, 2017: Vaccine
https://www.readbyqxmd.com/read/28746348/adolescent-values-for-immunisation-programs-in-australia-a-discrete-choice-experiment
#10
Bing Wang, Gang Chen, Julie Ratcliffe, Hossein Haji Ali Afzali, Lynne Giles, Helen Marshall
OBJECTIVES: The importance of adolescent engagement in health decisions and public health programs such as immunisation is becoming increasingly recognised. Understanding adolescent preferences and further identifying barriers and facilitators for immunisation acceptance is critical to the success of adolescent immunisation programs. This study applied a discrete choice experiment (DCE) to assess vaccination preferences in adolescents. METHODS: This study was conducted as a cross-sectional, national online survey in Australian adolescents...
2017: PloS One
https://www.readbyqxmd.com/read/28744935/emergency-department-presentations-in-infants-predictors-from-an-australian-birth-cohort
#11
Julia Crilly, Cate M Cameron, Paul A Scuffham, Norm Good, Rani Scott, Gabor Mihala, Amy Sweeny, Gerben Keijzers
AIM: Infants under 12 months of age are disproportionately represented amongst emergency department (ED) presentations, and infants are more likely to be frequent ED users. This study aimed to describe and identify psychosocial predictors of ED presentation in infants. METHODS: A prospective birth cohort from Queensland and New South Wales (Environments for Healthy Living) was used to understand infant health service use. Baseline and 12-month questionnaire data pertaining to children born between 2006 and 2011 were used to identify predictors of ED presentation, using multiple regression analysis...
July 25, 2017: Journal of Paediatrics and Child Health
https://www.readbyqxmd.com/read/28693751/cost-effectiveness-of-13-valent-pneumococcal-conjugate-vaccine-pcv13-in-older-australians
#12
S Dirmesropian, J G Wood, C R MacIntyre, P Beutels, P McIntyre, R Menzies, J F Reyes, C Chen, A T Newall
BACKGROUND: The 23-valent pneumococcal polysaccharide vaccine (PPV23) has been funded under the Australia National Immunisation Program (NIP) since January 2005 for those aged >65years and other risk groups. In 2016, PCV13 was accepted by the Pharmaceutical Benefits Advisory Committee (PBAC) as a replacement for a single dose of PPV23 in older Australian adults. METHODS: A single-cohort deterministic multi-compartment (Markov) model was developed describing the transition of the population between different invasive and non-invasive pneumococcal disease related health states...
August 3, 2017: Vaccine
https://www.readbyqxmd.com/read/28673213/primary-prevention-in-the-intensive-care-unit-a-prospective-single-centre-study-of-the-risk-factors-for-invasive-pneumococcal-disease
#13
A R Chapman, E L Litton
Invasive pneumococcal disease is a significant health burden in Australia, with immunisation recommended for children and at-risk adults. Health benefits of immunisation are clear, but less effective when immunisation rates are low, as in Western Australia. We hypothesised that patients admitted unplanned to the intensive care unit (ICU) would have high eligibility for pneumococcal immunisation, but low rates of recorded vaccine administration. We performed a prospective observational study of 119 emergency admissions to Royal Perth ICU, a 20-bed mixed ICU at a tertiary teaching hospital in Western Australia...
July 2017: Anaesthesia and Intensive Care
https://www.readbyqxmd.com/read/28604142/rubella-antibodies-in-australian-immunoglobulin-products
#14
Megan K Young, Joseph Bertolini, Pushpa Kotharu, Darryl Maher, Allan W Cripps
Rubella antibodies are not routinely measured in immunoglobulin products and there is a lack of information on the titer in Australian products. To facilitate future studies of the effectiveness of passive immunisation for preventing rubella and congenital rubella syndrome, this study measured the concentration of rubella-specific antibodies in Australian intramuscular (IM) and intravenous (IV) human immunoglobulin products suitable for post-exposure prophylaxis using a chemiluminescent immunoassay. The GMT ± GSD for the IM product was 19 ± 1...
August 3, 2017: Human Vaccines & Immunotherapeutics
https://www.readbyqxmd.com/read/28582563/participant-centred-active-surveillance-of-adverse-events-following-immunisation-a-narrative-review
#15
Patrick Cashman, Kristine Macartney, Gulam Khandaker, Catherine King, Michael Gold, David N Durrheim
The importance of active, participant-centred monitoring of adverse events following immunisation (AEFI) is increasingly recognised as a valuable adjunct to traditional passive AEFI surveillance. The databases OVID Medline and OVID Embase were searched to identify all published articles referring to AEFI. Only studies which sought participant response after vaccination were included. A total of 6060 articles published since the year 2000 were identified. After the application of screening inclusion and exclusion criteria, 25 articles describing 23 post-marketing AEFI systems were identified...
May 1, 2017: International Health
https://www.readbyqxmd.com/read/28560731/vaccine-discussions-with-parents-the-experience-of-australian-paediatricians
#16
Jessica Costa-Pinto, Harold W Willaby, Julie Leask, Nicholas Wood, Helen Marshall, Margie Danchin
AIM: Health-care providers are crucial in maintaining parental confidence in vaccination. Health-care providers are the most commonly accessed resource by parents for vaccine-related information and are highly trusted. We investigated paediatricians' (i) frequency of vaccine discussions; (ii) specific vaccine-related topics discussed; (iii) perceived role in childhood vaccination; (iv) challenges faced when having discussions; (v) confidence in vaccine-related knowledge and communication skills; and (vi) interest in online education and training...
September 2017: Journal of Paediatrics and Child Health
https://www.readbyqxmd.com/read/28385143/australian-childhood-immunisation-coverage-1-july-2015-and-30-june-2016-cohort-assessed-as-at-30-september-2016
#17
Alexandra J Hendry
No abstract text is available yet for this article.
March 31, 2017: Communicable Diseases Intelligence Quarterly Report
https://www.readbyqxmd.com/read/28385140/immunisation-coverage-annual-report-2014
#18
Brynley P Hull, Alexandra J Hendry, Aditi Dey, Frank H Beard, Julia M Brotherton, Peter B McIntyre
This 8th annual immunisation coverage report shows data for 2014 derived from the Australian Childhood Immunisation Register and the National Human Papillomavirus Vaccination Program Register. This report includes coverage data for 'fully immunised' and by individual vaccines at standard age milestones and timeliness of receipt at earlier ages according to Indigenous status. Overall, 'fully immunised' coverage has been mostly stable at the 12- and 24-month age milestones since late 2003, but at 60 months of age, it has increased by more than 10 percentage points since 2009...
March 31, 2017: Communicable Diseases Intelligence Quarterly Report
https://www.readbyqxmd.com/read/28385137/evaluation-of-bacille-calmette-gu%C3%A3-rin-immunisation-programs-in-australia
#19
Gulam Khandaker, Frank H Beard, Aditi Dey, Chris Coulter, Alexandra J Hendry, Kristine K Macartney
bacille Calmette-Guérin (BCG) immunisation programs in Australia are funded and operated by the individual states and territories. In recent years BCG vaccine shortages have required use of unregistered products. We aimed to evaluate BCG immunisation programs in Australia, with particular reference to program implementation and national consistency.
 Methods: Between September and November 2015, 12 key stakeholders, representing Australian states and territories, completed surveys. We analysed BCG vaccination coverage data from the Australian Childhood Immunisation Register (ACIR), and data on adverse events following immunisation (AEFI) with BCG vaccine from the Therapeutic Goods Administration's Adverse Drug Reactions System, for 2001 to 2014...
March 31, 2017: Communicable Diseases Intelligence Quarterly Report
https://www.readbyqxmd.com/read/28342074/evaluation-of-saefvic-a-pharmacovigilance-surveillance-scheme-for-the-spontaneous-reporting-of-adverse-events-following-immunisation-in-victoria-australia
#20
Hazel J Clothier, Nigel W Crawford, Melissa Russell, Heath Kelly, Jim P Buttery
INTRODUCTION: Australia is traditionally an early adopter of vaccines, therefore comprehensive and effective post-licensure vaccine pharmacovigilance is critical to maintain confidence in immunisation, both nationally and internationally. With adverse event following immunisation (AEFI) surveillance the responsibility of Australian jurisdictions, Victoria operates an enhanced passive AEFI surveillance system integrated with clinical services, called 'SAEFVIC' (Surveillance of Adverse Events Following Vaccination In the Community)...
June 2017: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
keyword
keyword
8714
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"